Evernorth is trading 7.6% down at $11.07; available coverage has not confirmed a company-specific catalyst for the decline. - A recent filing registering shares for potential resale may raise supply-overhang concerns, but coverage does not establish it as the direct cause of the November 4 decline. - The registration does not mean all covered shares are immediately available for sale. - The broader market and healthcare sector are higher; current trading volume was not found in available coverage.